Conduit Pharmaceuticals Inc.
CDT
$0.6201
-$0.16-20.51%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3,227.48% | -293.43% | 27.07% | 61.37% | 89.05% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 246.61% | 867.15% | -143.09% | -252.81% | -330.77% |
| Change in Net Operating Assets | 95.35% | -158.20% | -307.42% | -601.98% | -522.15% |
| Cash from Operations | -25.35% | -180.77% | -146.63% | -135.34% | -240.86% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -98.90% | 141.38% | 1,690.91% | 327.23% | 496.17% |
| Cash from Investing | -105.93% | 112.07% | 1,645.45% | 327.23% | 496.17% |
| Total Debt Issued | 41.12% | -60.95% | -98.29% | -98.02% | 106.50% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2,220.53% | -82.78% | -48.34% | -73.92% | -88.96% |
| Repurchase of Common Stock | -- | -- | 96.30% | 96.30% | 96.30% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -98.67% | -99.05% | -- | -- | -- |
| Cash from Financing | -44.49% | -88.25% | 137.81% | 124.52% | 346.45% |
| Foreign Exchange rate Adjustments | -105.35% | 7,275.00% | 3,212.50% | 27,000.00% | 29,800.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -186.90% | -199.18% | 661.54% | 30,500.00% | -- |